Aromatase inhibitors for the treatment of endometriosis
review
OA: bronze
CC0
⤵ 95 in-corpus citations
AI-generated summary
This paper investigated aromatase inhibitors as a treatment for endometriosis and reported their findings.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (69)
- 17β-Hydroxysteroid Dehydrogenase-2 Deficiency and Progesterone Resistance in Endometriosis via openalex
- Anastrazole and oral contraceptives: a novel treatment for endometriosis via openalex
- Aromatase and other steroidogenic genes in endometriosis: translational aspects via openalex
- Aromatase in endometriosis and uterine leiomyomata via openalex
- Aromatase inhibitors in post-menopausal endometriosis via openalex
- Aromatase Inhibitors in the Treatment of Severe Endometriosis via openalex
- Aromatase inhibitors: the next generation of therapeutics for endometriosis? via openalex
- Cancer risk after a hospital discharge diagnosis of endometriosis via openalex
- Cancer risk after hospital discharge diagnosis of benign ovarian cysts and endometriosis via openalex
- Distinct mechanisms regulate cyclooxygenase-1 and -2 in peritoneal macrophages of women with and without endometriosis via openalex
- Endometriosis via openalex
- Endometriosis via openalex
- Endometriosis arising during estrogen and testosterone treatment 17 years after abdominal hysterectomy: a case report via openalex
- Estrogen Receptor-β, Estrogen Receptor-α, and Progesterone Resistance in Endometriosis via openalex
- Expression of Aromatase Cytochrome P450 Protein and Messenger Ribonucleic Acid in Human Endometriotic and Adenomyotic Tissues but not in Normal Endometrium1 via openalex
- Genetic or Enzymatic Disruption of Aromatase Inhibits the Growth of Ectopic Uterine Tissue via openalex
- Letrozole and desogestrel‐only contraceptive pill for the treatment of stage IV endometriosis via openalex
- Letrozole and norethisterone acetate in colorectal endometriosis via openalex
- Letrozole and norethisterone acetate in rectovaginal endometriosis via openalex
- Letrozole and norethisterone acetate versus letrozole and triptorelin in the treatment of endometriosis related pain symptoms: a randomized controlled trial via openalex
- Persistent bilateral ureteral obstruction secondary to endometriosis despite treatment with an aromatase inhibitor via openalex
- Pharmacological Treatment of Endometriosis via openalex
- Prostaglandin E2 Via Steroidogenic Factor-1 Coordinately Regulates Transcription of Steroidogenic Genes Necessary for Estrogen Synthesis in Endometriosis via openalex
- Role of the vaginally administered aromatase inhibitor anastrozole in women with rectovaginal endometriosis: a pilot study via openalex
- Steroidogenic factor-1 and endometriosis via openalex
- Steroid receptor and aromatase expression in baboon endometriotic lesions via openalex
- Stromal cells of endometriosis fail to produce paracrine factors that induce epithelial 17β-hydroxysteroid dehydrogenase type 2 gene and its transcriptional regulator Sp1: a mechanism for defective estradiol metabolism via openalex
- Successful treatment of an aggressive recurrent post-menopausal endometriosis with an aromatase inhibitor via openalex
- Successful treatment of severe endometriosis in two premenopausal women with an aromatase inhibitor via openalex
- The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trial via openalex
- Treatment of Severe Postmenopausal Endometriosis With an Aromatase Inhibitor via openalex
- Treatment of severe recurrent endometriosis with an aromatase inhibitor in a young ovariectomised woman via openalex
- Vesical and vaginal recurrent endometriosis in postmenopause following estrogen replacement therapy via openalex
- W2111226394 via openalex
- W1977482986 via openalex
- W2145213731 via openalex
- W2146483619 via openalex
- W2148226416 via openalex
- W1973335161 via openalex
- W2157853773 via openalex
- W2159369450 via openalex
- W2159803441 via openalex
- W1971526128 via openalex
- W2163322699 via openalex
- W1599466832 via openalex
- W2319996195 via openalex
- W2438288971 via openalex
- W4211081176 via openalex
- W187717610 via openalex
- W4232360933 via openalex
- W6607494081 via openalex
- W6643602951 via openalex
- W6717957469 via openalex
- W2034951181 via openalex
- W6813875875 via openalex
- W2037828179 via openalex
- W2045191522 via openalex
- W2047518704 via openalex
- W2054617985 via openalex
- W2066865081 via openalex
- W2067202752 via openalex
- W2076358748 via openalex
- W2080516316 via openalex
- W2089803739 via openalex
- W2017521059 via openalex
- W2096446019 via openalex
- W2000519574 via openalex
- W1994499380 via openalex
- W1987520465 via openalex
Cited by (50)
- Cancer-like Hallmarks of Endometriosis: The Role of Estrogen Signaling and Stem Cell Plasticity 2026
- Hormonal Dysregulation and Neuroinflammation in Endometriosis: Convergent Druggable Pathways 2026
- Lignes directrices de pratique clinique n° 468 : Prise en charge clinique de l'endométriose 2026
- Endometriosis and menopausal health: An EMAS clinical guide 2025
- The "double-edged sword" effect of non-steroidal anti-inflammatory drugs (NSAIDs) in the treatment of endometriosis (EMS) 2025
- Medical management of endometriosis 2024
- Shared Pathogenic and Therapeutic Characteristics of Endometriosis, Adenomyosis, and Endometrial Cancer: A Comprehensive Literature Review 2024
- Evaluating the Relative Efficacy of Synthetic and Natural Drugs in Endometriosis Adopting Molecular Modelling Approach 2024
- How to Protect Fertility Potential in Endometriosis 2024
- Pain Management for Women with Endometriosis 2024
- Endometriosis: Pathogenesis, Diagnosis and Treatment, volume II 2024
- Endometriosis: A Comprehensive and Concise Review of Potential Biomarkers and Treatment Therapies 2024
- Neuroimmunology of Endometriosis-Associated Pain and Its Psychological Aspects 2024
- Aromatase inhibitors in the pharmacotherapy of endometriosis 2023
- Diagnostic and Therapeutic Approaches for Endometriosis: A Patent Landscape 2023
- A Systematic Review of Systematic Reviews on the Use of Aromatase Inhibitors for the Treatment of Endometriosis: The Evidence to Date 2023
- Importance of Medicinal Compounds from Traditional Plants for the Treatment of Endometriosis 2023
- Evaluation of aromatase expression in endometrioid heterotopias and endometria in patients with external genital endometriosis 2023
- Diagnostic and therapeutic approaches for endometriosis: a patent landscape 2023
- Interferon Signaling in the Endometrium and in Endometriosis 2022
- Evaluation of the potential role of diethylstilbestrol on the induction of endometriosis in a rat model - An alternative approach 2022
- Co-treatment of gonadotropin and letrozole in infertile women with endometriosis: A double-blind randomized clinical trial 2022
- Is intracrinology of endometriosis relevant in clinical practice? A systematic review on estrogen metabolism 2022
- Endometriosis: A Disease with Few Direct Treatment Options 2022
- Advances in targeting estrogen synthesis and receptors in patients with endometriosis 2022
- Treatment of endometriosis: a review with comparison of 8 guidelines 2021
- Adenomyosis pathogenesis: insights from next-generation sequencing 2021
- Symptom control after different duration of triptorelin treatment following conservative surgery for deep infiltrating endometriosis 2021
- The Effect of Letrozole Combined with Dydrogesterone for Endometriosis in China: A Meta‐Analysis 2021
- Evaluation of the effect of aromatase inhibitor in reducing the size of endometrioma 2021
- Use of aromatase inhibitors in menopausal deep endometriosis: a case report and literature review 2021
- Additional file 1 of Anastrozole and levonorgrestrel-releasing intrauterine device in the treatment of endometriosis: a randomized clinical trial 2021
- Nonsurgical mouse model of endometriosis-associated pain that responds to clinically active drugs 2020
- Anastrozole and Levonorgrestrel-Releasing Intrauterine Device in the Treatment of Endometriosis: A Randomized Clinical Trial. 2020
- Endometriosis in Menopause—Renewed Attention on a Controversial Disease 2020
- Discerning Endometriosis as a Multifaceted Entity: A Comprehensive Review 2020
- Novel Medicine for Endometriosis and Its Therapeutic Effect in a Mouse Model 2020
- Anastrozole and Levonorgrestrel-Releasing Intrauterine Device in the Treatment of Endometriosis: A Randomized Clinical Trial. 2020
- Androgens, oestrogens and endometrium: a fine balance between perfection and pathology 2020
- Anastrozole and Levonorgrestrel-Releasing Intrauterine Device in the Treatment of Endometriosis: A Randomized Clinical Trial. 2020
- Endometriosis Pain Management: a Review 2020
- Letrozole combined with oral contraceptives versus oral contraceptives alone in the treatment of endometriosis-related pain symptoms: a pilot study 2020
- Endometriosis Treatment 2020
- Superior hypogastric plexus block as an effective treatment method for endometriosis-related chronic pelvic pain: an open-label pilot clinical trial 2020
- Anastrozole and Levonorgrestrel-Releasing Intrauterine Device in the Treatment of Endometriosis: A Randomized Clinical Trial. 2020
- Hormonal Replacement Therapy in Menopausal Women with History of Endometriosis: A Review of Literature 2019
- Postoperative Hormonal Suppression for Prevention of Deeply Infiltrative Endometriosis Recurrence After Surgery 2018
- Tratamientos farmacológicos de la endometriosis (a excepción de la adenomiosis) 2018
- Pathogenesis of endometriosis: Interaction between Endocrine and inflammatory pathways 2018
- Medical and Surgical Management of Endometriosis 2018
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:16:04.919516+00:00
License: CC0
· commercial use OK